Owners, management and financials
CVR: 26902398
Secondary names: MISSIONPHARMA INTERNATIONAL PROJECT SERVICES A/S, MISSIONPHARMA INTERNATIONAL RELIEF SERVICES A/S, MISSIONPHARMA INTERNATIONAL A/S
DKK 934,465,000
Revenue
Net result: DKK 120,205,000
CFAO HEALTHCARE SA (100%)
CVR · view owners
Nicolai Buhl Andersen, Edouard Marc Marie Favreau
Board: Jean-Marc Pierre René Leccia (chair) and 3 members
CVR · view management
Active
Founded 6 December 2002
CVR · view overview
60 employees
CVR · 2018
Director registered: Nicolai Buhl Andersen
CVR · 01/09/2026
View the full event history
MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nicolai Buhl Andersen and Edouard Marc Marie Favreau. The board consists of Jean-Marc Pierre René Leccia (chair), Kim Erik Ginnerup, Eric Pierre Jean Muris and Ilona Maureen Fischer. The company is owned by CFAO HEALTHCARE SA. The company has 60 employees (2018). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.
Source: annual report 2026, Danish Business Authority
MISSIONPHARMA A/S exhibits strong financial health, characterized by a solid profitability trend and increasing revenue. In 2026, the company reported revenue of 934.5 million DKK and a profit of 120.2 million DKK, reflecting a significant rise from 741.9 million DKK in revenue and 73.4 million DKK in profit in 2025. The equity position remains robust at 317.8 million DKK, although there was a slight decline from the previous year's equity of 340.8 million DKK. With consistent gross profit margins and a stable market presence in the pharmaceutical wholesale industry, MISSIONPHARMA A/S is well-positioned for future growth despite minor fluctuations in revenue over the past few years.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive handel og industri.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/04/2025 – 31/03/2026 | 934.5 mio. | 120.2 mio. | 464.9 mio. | 317.8 mio. | 170 | |
| 202501/04/2024 – 31/03/2025 | 742 mio. | 73.4 mio. | 403.2 mio. | 273.1 mio. | 169 | |
| 202401/04/2023 – 31/03/2024 | 940.1 mio. | 119.9 mio. | 470.4 mio. | 319.3 mio. | 158 | |
| 202301/04/2022 – 31/03/2023 | 942.5 mio. | 119.2 mio. | 538.2 mio. | 340.8 mio. | 58 | |
| 202201/04/2021 – 31/03/2022 | 694 mio. | 58 mio. | 428.5 mio. | 312.8 mio. | 55 | |
| 202101/04/2020 – 31/03/2021 | 731.5 mio. | 83.6 mio. | 427.2 mio. | 332.4 mio. | 58 | |
| 202001/04/2019 – 31/03/2020 | 777 mio. | 22.2 mio. | 381 mio. | 263.2 mio. | 62 | |
| 201901/04/2018 – 31/03/2019 | 117.2 mio. | 6 mio. | 58.9 mio. | 40.6 mio. | 62 | |
| 201701/01/2017 – 31/12/2017 | 703.5 mio. | 76.2 mio. | 438.5 mio. | 284 mio. | 60 | |
| 201601/01/2016 – 31/12/2016 | 762.7 mio. | 78 mio. | 321.6 mio. | 209 mio. | 57 | |
| 201501/01/2015 – 31/12/2015 | 753.9 mio. | 73.8 mio. | 311.1 mio. | 185.5 mio. | 49 | |
| 201401/01/2014 – 31/12/2014 | 703.8 mio. | 69 mio. | 317.6 mio. | 162.3 mio. | 42 | |
| 201301/01/2013 – 31/12/2013 | 537.9 mio. | 44.1 mio. | 214.2 mio. | 124.4 mio. | 45 |
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Property report (PDF)
The entire property portfolio in one report: areas, usage, energy labels, flood exposure, planning zone and local plans.
See an example report (PDF)Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of MISSIONPHARMA A/S is 26902398.
MISSIONPHARMA A/S is owned by CFAO HEALTHCARE SA.
The management of MISSIONPHARMA A/S consists of Nicolai Buhl Andersen and Edouard Marc Marie Favreau.
The board of MISSIONPHARMA A/S consists of Jean-Marc Pierre René Leccia, Kim Erik Ginnerup and Eric Pierre Jean Muris, with Jean-Marc Pierre René Leccia as chair.
In 2026, MISSIONPHARMA A/S reported revenue of DKK 934,465,000.
MISSIONPHARMA A/S had 60 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 48163200, new email: [email protected] (September 7, 2026).
As of September 1, 2026, Nicolai Buhl Andersen is registered as adm. dir. of MISSIONPHARMA A/S.
As of September 1, 2026, Edouard Marc Marie Favreau is registered as director of MISSIONPHARMA A/S.
As of September 1, 2026, Christian Monrad Overgaard has stepped down as adm. dir. of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2026. Revenue came to DKK 934,465,000, and the net result was DKK 120,205,000.
Contact info changed: new phone: 48163200, new email: [email protected] (June 19, 2026).
As of June 15, 2026, Alexandre Pierre Jean Vialatte has stepped down as director of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2025. Revenue came to DKK 741,955,000, and the net result was DKK 73,402,000.
MISSIONPHARMA A/S has published its annual report for 2024. Revenue came to DKK 940,120,000, and the net result was DKK 119,865,000.
As of December 15, 2023, is registered as an owner of MISSIONPHARMA A/S with an ownership share of 100%.
MISSIONPHARMA A/S has published its annual report for 2023. Revenue came to DKK 942,492,000, and the net result was DKK 119,159,000.
As of May 25, 2023, Ilona Maureen Fischer has joined the board of directors of MISSIONPHARMA A/S.
As of May 25, 2023, Patricia Hec has left the board of directors of MISSIONPHARMA A/S.
As of February 1, 2023, Aymeric Erouart has left the board of directors of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2022. Revenue came to DKK 693,959,000, and the net result was DKK 57,982,000.
As of June 29, 2022, Forvis Mazars Statsautoriseret Revisionspartnerselskab has been appointed auditor of MISSIONPHARMA A/S.
As of June 29, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MISSIONPHARMA A/S.
As of November 30, 2021, Alexandre Pierre Jean Vialatte is registered as director of MISSIONPHARMA A/S.
As of November 30, 2021, Poul Lindof has stepped down as økonomidirektør of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2021. Revenue came to DKK 731,472,000, and the net result was DKK 83,607,000.
As of December 3, 2020, Patricia Hec has joined the board of directors of MISSIONPHARMA A/S.
As of December 3, 2020, Annie Renée Simonne Dateu has left the board of directors of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2020. Revenue came to DKK 776,981,000, and the net result was DKK 22,237,000.
MISSIONPHARMA A/S has published its annual report for 2019. Revenue came to DKK 117,236,000, and the net result was DKK 6,010,000.
As of February 13, 2019, Kim Erik Ginnerup has joined the board of directors of MISSIONPHARMA A/S.
As of February 13, 2019, Aymeric Erouart has joined the board of directors of MISSIONPHARMA A/S.
As of February 13, 2019, Annie Renée Simonne Dateu has joined the board of directors of MISSIONPHARMA A/S.
As of February 12, 2019, Kim Erik Ginnerup has left the board of directors of MISSIONPHARMA A/S.
As of August 30, 2018, Christian Monrad Overgaard is registered as adm. dir. of MISSIONPHARMA A/S.
As of August 30, 2018, Kim Erik Ginnerup has stepped down as adm. dir. of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its interim report for the period January 1, 2018 – March 31, 2018.
MISSIONPHARMA A/S has published its annual report for 2017. Revenue came to DKK 703,475,000, and the net result was DKK 76,150,000.
As of March 31, 2018, Denis Georges Fernand Maurice has left the board of directors of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2016. Revenue came to DKK 762,676,000, and the net result was DKK 78,005,000.
MISSIONPHARMA A/S has published its annual report for 2015. Revenue came to DKK 753,910,000, and the net result was DKK 73,845,000.
MISSIONPHARMA A/S has published its annual report for 2014. Revenue came to DKK 703,768,000, and the net result was DKK 69,003,000.
As of April 20, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MISSIONPHARMA A/S.
As of April 20, 2015, KPMG P/S has stepped down as auditor of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its annual report for 2013. Revenue came to DKK 537,927,000, and the net result was DKK 44,083,000.
As of May 27, 2014, KPMG P/S has been appointed auditor of MISSIONPHARMA A/S.
As of May 27, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of MISSIONPHARMA A/S.
MISSIONPHARMA A/S has published its interim report for the period May 1, 2012 – December 31, 2012.
As of March 15, 2013, Kim Erik Ginnerup is registered as adm. dir. of MISSIONPHARMA A/S.
As of March 15, 2013, Mikkel Mørkedal Wakefield has stepped down as adm. dir. of MISSIONPHARMA A/S.
As of November 30, 2012, Mikkel Mørkedal Wakefield is registered as adm. dir. of MISSIONPHARMA A/S.
As of November 20, 2012, EY Godkendt Revisionspartnerselskab has been appointed auditor of MISSIONPHARMA A/S.
As of November 20, 2012, JUT NR. 2180 A/S has stepped down as auditor of MISSIONPHARMA A/S.
As of November 1, 2012, Kim Erik Ginnerup has joined the board of directors of MISSIONPHARMA A/S.
As of November 1, 2012, Jean-Marc Pierre René Leccia has joined the board of directors of MISSIONPHARMA A/S.
As of November 1, 2012, Denis Georges Fernand Maurice has joined the board of directors of MISSIONPHARMA A/S.
As of July 18, 2012, Eric Pierre Jean Muris has joined the board of directors of MISSIONPHARMA A/S.
As of July 18, 2012, Leif Ole Lund-Andersen has left the board of directors of MISSIONPHARMA A/S.
As of July 18, 2012, Peter Normann has left the board of directors of MISSIONPHARMA A/S.
As of July 18, 2012, Jesper Ahlmann Funding Andersen has left the board of directors of MISSIONPHARMA A/S.
As of July 18, 2012, Paule Georgette Ginnerup has left the board of directors of MISSIONPHARMA A/S.
As of December 15, 2010, Leif Ole Lund-Andersen has joined the board of directors of MISSIONPHARMA A/S.
As of December 15, 2010, Leif Ole Lund-Andersen has left the board of directors of MISSIONPHARMA A/S.
As of December 15, 2010, Kim Erik Ginnerup has stepped down as director of MISSIONPHARMA A/S.
As of September 2, 2010, JUT NR. 2180 A/S has been appointed auditor of MISSIONPHARMA A/S.
As of September 2, 2010, EY Danmark A/S has stepped down as auditor of MISSIONPHARMA A/S.
As of January 4, 2010, Poul Lindof is registered as økonomidirektør of MISSIONPHARMA A/S.
As of January 4, 2010, Christian Ilsøe has stepped down as økonomidirektør of MISSIONPHARMA A/S.
As of September 25, 2009, Peter Normann has joined the board of directors of MISSIONPHARMA A/S.
As of September 15, 2008, Christian Ilsøe is registered as økonomidirektør of MISSIONPHARMA A/S.
As of November 22, 2007, Poul Lindof has stepped down as director of MISSIONPHARMA A/S.
As of December 4, 2006, Alan Per Binau has left the board of directors of MISSIONPHARMA A/S.
As of October 31, 2006, Erik Schou Stavnstrup has stepped down as director of MISSIONPHARMA A/S.
As of September 18, 2006, Henning Brømsøe Termansen has left the board of directors of MISSIONPHARMA A/S.
As of June 22, 2005, Poul Lindof is registered as director of MISSIONPHARMA A/S.
As of November 30, 2004, EY Danmark A/S has been appointed auditor of MISSIONPHARMA A/S.
As of November 30, 2004, NIELS HARDER A/S has stepped down as auditor of MISSIONPHARMA A/S.
As of August 18, 2004, Henning Brømsøe Termansen has joined the board of directors of MISSIONPHARMA A/S.
As of August 18, 2004, Kim Erik Ginnerup has left the board of directors of MISSIONPHARMA A/S.
As of August 18, 2004, Erik Schou Stavnstrup has left the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, NIELS HARDER A/S has been appointed auditor of MISSIONPHARMA A/S.
As of December 6, 2002, Leif Ole Lund-Andersen has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Kim Erik Ginnerup has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Erik Schou Stavnstrup has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Alan Per Binau has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Jesper Ahlmann Funding Andersen has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Paule Georgette Ginnerup has joined the board of directors of MISSIONPHARMA A/S.
As of December 6, 2002, Kim Erik Ginnerup is registered as director of MISSIONPHARMA A/S.
As of December 6, 2002, Erik Schou Stavnstrup is registered as director of MISSIONPHARMA A/S.
MISSIONPHARMA A/S was founded on December 6, 2002.
Companies in the same industry and area
CVR 20041587
CVR 29819521
CVR 19056007
CVR 25272765
CVR 37150363
